 effect sinorphan enkephalinas inhibitor plasma atrial natriuret factor sodium urinari excret cirrhot patient ascit acut effect sinorphan inhibitor enkephalinas plasma atrial natriuret factor anf urinari sodium excret cirrhot patient ascit singl oral dose sinorphan mg patient placebo doubl blind cross-ov protocol basal plasma anf level larg rang pmol/l sinorphan dose mg plasma enkephalinas activ min ingest increas plasma anf cgmp level time basal valu transient increas sodium urinari output chang creatinin clearanc initi period drug administr increas urinari cgmp period plasma aldosteron concentr peak plasma anf mean blood pressur pra effect mg plasma anf cgmp aldosteron signific dose enkephalinas inhibit sodium urinari excret cirrhot patient ascit mechan like reduct anf catabol result anf role control sodium homeostasi liver cirrhosi ascit